z-logo
open-access-imgOpen Access
Concurrent use of aromatase inhibitors and hypofractionated radiation therapy
Author(s) -
Cyrus Chargari,
Pablo Castro-Pena,
I. Toledano,
Bollet Ma,
Alexia Savigi,
PaulHenri Cottu,
Fatima Laki,
F. Campana,
de Cremoux P,
A. Fourquet,
Kirova Ym
Publication year - 2012
Publication title -
world journal of radiology
Language(s) - English
Resource type - Journals
ISSN - 1949-8470
DOI - 10.4329/wjr.v4.i7.318
Subject(s) - medicine , toxicity , adverse effect , acute toxicity , breast cancer , radiation therapy , cancer , gastroenterology , urology
To retrospectively assess the acute and long-term toxicity using aromatase inhibitors (AI) therapy concurrently with hypofractionated radiotherapy (HFRT) in breast cancer patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here